These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 843124)

  • 1. Evaluation of a breast cyst fluid protein detectable in the plasma of breast carcinoma patients.
    Haagensen DE; Mazoujian G; Holder WD; Kister SJ; Wells SA
    Ann Surg; 1977 Mar; 185(3):279-85. PubMed ID: 843124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of carcinoembryonic antigen as a plasma monitor for human breast carcinoma.
    Haagensen DE; Kister SJ; Vandevoorde JP; Gates JB; Smart EK; Hansen HJ; Wells SA
    Cancer; 1978 Sep; 42(3 Suppl):1512-9. PubMed ID: 709523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast gross cystic disease fluid analysis. I. Isolation and radioimmunoassay for a major component protein.
    Haagensen DE; Mazoujian G; Dilley WG; Pedersen CE; Kister SJ; Wells SA
    J Natl Cancer Inst; 1979 Feb; 62(2):239-47. PubMed ID: 283260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of serial plasma levels of carcinoembryonic antigen and gross cyst disease fluid protein in patients with breast carcinoma and osseous metastases.
    Haagensen DE; Barry WF; McCook TA; Giannola J; Ammirata S; Wells SA
    Ann Surg; 1980 May; 191(5):599-603. PubMed ID: 7369822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum oestradiol-17 beta in women with benign and malignant breast disease.
    England PC; Skinner LG; Cottrell KM; Sellwood RA
    Br J Cancer; 1974 Dec; 30(6):571-6. PubMed ID: 4447785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prolactin. Radioimmunoassay in female breast cancers and benign mastopathies].
    Gorins A; Netter A
    Nouv Presse Med; 1974 Jan; 3(2):73-5. PubMed ID: 4815434
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum protein bound hexoses in patients with breast cancer.
    Rosato FE; Ravdin RG
    Cancer Res; 1968 Jan; 28(1):44-5. PubMed ID: 5635371
    [No Abstract]   [Full Text] [Related]  

  • 8. Proceedings: Serum oestradiol 17 beta in normal premenopausal women and in patients with benign and malignant breast disease.
    Skinner LG; England PC; Cottrell KM; Selwood RA
    Br J Cancer; 1974 Aug; 30(2):176-7. PubMed ID: 4419442
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative evaluation of carcinoembryonic antigen and gross cystic disease fluid protein as plasma markers for human breast carcinoma.
    Haagensen DE; Kister SJ; Panick J; Giannola J; Hansen HJ; Wells SA
    Cancer; 1978 Sep; 42(3 Suppl):1646-52. PubMed ID: 709529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoembryonic-like substance in breast fluid discharge in benign and malignant breast disease and in milk of lactating women.
    Kahana L; Bartal AH; Yechieli H; Guttman I; Sheinfeld M
    Isr J Med Sci; 1981 Nov; 17(11):1035-40. PubMed ID: 7319791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical recognition of cystic carcinoma of the breast.
    Devitt JE; Barr JR
    Surg Gynecol Obstet; 1984 Aug; 159(2):130-2. PubMed ID: 6463821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of placental protein five (PP5) and pregnancy-specific glycoprotein (SP1) in benign and malignant breast disease.
    Bremner RD; Nisbet AD; Herriot R; Horne CH; McArdle C; Crawford D; Bohn H
    Oncodev Biol Med; 1981; 2(1-2):55-62. PubMed ID: 6975467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship of gross cystic disease of the breast and carcinoma.
    Haagensen CD
    Ann Surg; 1977 Mar; 185(3):375-6. PubMed ID: 843133
    [No Abstract]   [Full Text] [Related]  

  • 14. Double antibody radioimmunoassay for monitoring metastatic breast cancer.
    Schecter RL; Major PP; Kovac PE; Ishida M; Kovalik EC; Dion AS; Langleben A; Boileau G; Boos G; Panasci L
    Br J Cancer; 1988 Sep; 58(3):362-7. PubMed ID: 3179189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmunoassay of human epidermal growth factor in human breast cyst fluid.
    Jaspar JM; Franchimont P
    Eur J Cancer Clin Oncol; 1985 Nov; 21(11):1343-8. PubMed ID: 3878296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibronectin concentration in the plasma of patients with malignant and benign breast disease.
    Boccardo F; Guarneri D; Zanardi S; Castellani P; Borsi L; Zardi L
    Cancer Lett; 1986 Dec; 33(3):317-23. PubMed ID: 3802060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of secretory component in patients with metastatic breast cancer.
    Puleo EA; Haagensen DE; Dawson JR; Gall SA
    Am J Obstet Gynecol; 1979 Aug; 134(8):899-903. PubMed ID: 223446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioimmunoassay for the measurement of thrombospondin in plasma and breast cyst fluid: validation and clinical application.
    Hayden K; Tetlow L; Byrne G; Bundred N
    Ann Clin Biochem; 2000 May; 37 ( Pt 3)():319-25. PubMed ID: 10817245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytology of large cysts of the breast].
    Zolotarevskiĭ VB; Bukhteeva NF; Kogan EA
    Arkh Patol; 1979; 41(4):43-8. PubMed ID: 444087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [HCG-determinations in serum and mammary cyst aspirates in women with benign breast tumors (author's transl)].
    Opri F; Post G; Kirchner H; Hammerstein J
    Geburtshilfe Frauenheilkd; 1979 Aug; 39(8):690-3. PubMed ID: 478270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.